Amarin Corp Plc (AMRN)

[ORBAPU]

Evidence continues to build that COVID increases CVD risk. Seems plausible that Vascepa would be of benefit. Hopefully some entity is contemplating a trial. Real world evidence could perhaps be a resource.

https://arstechnica.com/science/2022/02/covid-raised-heart-risks-63-for-a-year-after-infection-in-study-of-11m-people/